[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100627941":3},{"organization":4,"armGroups":7,"interventions":16,"overallOfficials":20,"centralContacts":25,"locations":31,"responsibleParty":45,"collaborators":10,"id":47,"slug":10,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":50,"acronym":10,"eligibilityCriteria":51,"healthyVolunteers":52,"sex":53,"minAge":54,"maxAge":55,"enrollmentInfo":56,"targetDuration":10,"studyType":59,"phases":10,"briefSummary":60,"conditions":61,"keywords":10,"overallStatus":62,"whyStopped":10,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":72},{"fullName":5,"class":6},"Zhujiang Hospital","OTHER",[8,13],{"label":9,"type":10,"description":10,"interventionNames":11},"Cirrhosis",null,[12],"Other: observational study, no intervention",{"label":14,"type":10,"description":10,"interventionNames":15},"Healthy control",[12],[17],{"type":6,"name":18,"description":18,"armGroupLabels":19,"otherNames":10},"observational study, no intervention",[9,14],[21],{"name":22,"affiliation":23,"role":24},"Xiaolong He","Southern Medical University, China","STUDY_DIRECTOR",[26],{"name":27,"role":28,"phone":29,"phoneExt":10,"email":30},"Yi Xu","CONTACT","+86 13364060425","xuyi2410@hotmail.com",[32],{"facility":33,"status":10,"city":34,"state":35,"zip":36,"country":37,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":10},"Zhujiang Hospital of Southern Medical University","Guangzhou","Guangdong","510000","China","CN",{"type":40,"coordinates":41},"Point",[42,43],113.25,23.11667,{"lat":43,"lon":42},{"type":46,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100627941",false,"NCT07455175","Observational Clinical Study on the Association Between Lactate-mediated Gut Microbiota Alterations and Disease Progression in Liver Cirrhosis.","Inclusion Criteria:\n\n\\- 1. Healthy individuals without a history of liver disease or related underlying disorders; or patients diagnosed with liver cirrhosis and its complications based on imaging and\u002For liver biopsy, with a history of chronic liver disease for more than 6 months. Etiologies include chronic hepatitis B virus infection, nonalcoholic fatty liver disease, and alcoholic liver disease, among others.\n\n2\\. Willing to participate in this study and able to provide written informed consent.\n\nExclusion Criteria:\n\n* 1\\. A history of severe organic diseases involving the liver, gastrointestinal tract, kidneys, or other organ systems; malignant tumors; or autoimmune diseases.\n\n  2\\. Patients with acute infection or inflammatory diseases within the past 1 month.\n\n  3\\. Pregnant or breastfeeding women.",true,"ALL","18 Years","80 Years",{"count":57,"type":58},200,"ESTIMATED","OBSERVATIONAL","To investigate the association between lactate-mediated alterations in the gut microbiota and disease progression in patients with liver cirrhosis; and to examine the correlations of lactate levels among serum, fecal, and tissue samples in patients with liver cirrhosis.",[9],"NOT_YET_RECRUITING","2026-03-03",{"date":65,"type":66},"2026-03-06","ACTUAL",{"date":68,"type":58},"2026-04-01",{"date":70,"type":58},"2028-10-01",{"name":5,"class":6},1]